propidium has been researched along with Movement Disorders in 3 studies
Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, YX | 1 |
| Dai, DK | 1 |
| Liu, R | 1 |
| Wang, T | 1 |
| Luo, CL | 1 |
| Bao, HJ | 1 |
| Yang, R | 1 |
| Feng, XY | 1 |
| Qin, ZH | 1 |
| Chen, XP | 1 |
| Tao, LY | 1 |
| Bermpohl, D | 1 |
| You, Z | 1 |
| Lo, EH | 1 |
| Kim, HH | 1 |
| Whalen, MJ | 1 |
| Chen, S | 1 |
| Peng, ZC | 1 |
| Bertini, G | 1 |
3 other studies available for propidium and Movement Disorders
| Article | Year |
|---|---|
Therapeutic effect of SN50, an inhibitor of nuclear factor-κB, in treatment of TBI in mice.
Topics: Animals; BH3 Interacting Domain Death Agonist Protein; Brain; Brain Injuries; Caspase 3; Cathepsin B | 2013 |
TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice.
Topics: Animals; Antibodies, Blocking; Brain Edema; Brain Injuries; Cell Count; Cognition; Coloring Agents; | 2007 |
Neural substrate of a cerebellar movement disorder induced by intracerebroventricular injection of propidium iodide in the rat: a Fos immunocytochemical study.
Topics: Animals; Brain; Cerebellar Diseases; Female; Immunohistochemistry; Injections, Intraventricular; Mal | 1994 |